Financials Genertec Universal Medical Group Company Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:09:05 2024-06-07 am EDT			5-day change	1st Jan Change
4.57 ^HKD	+0.44%		+2.93%	+1.78%

Jun. 05	Genertec Universal Medical Group Completes Issuance of T4 Bonds in China	MT
May. 31	Genertec Universal Medical Unit to Raise 1 Billion Yuan from Corporate Bond Issue	MT

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	9,049	8,364	8,677	7,919	7,719	8,019	-	-
Enterprise Value (EV) ¹	43,125	8,364	8,677	7,919	7,719	8,019	8,019	8,019
P/E ratio	6.06 x	5.08 x	5.04 x	4.5 x	4.12 x	3.99 x	3.66 x	3.53 x
Yield	5.01%	5.36%	6.38%	7.12%	7.92%	7.94%	8.3%	8.85%
Capitalization / Revenue	1.33 x	0.98 x	0.88 x	0.66 x	0.57 x	0.55 x	0.5 x	0.46 x
EV / Revenue	1.33 x	0.98 x	0.88 x	0.66 x	0.57 x	0.55 x	0.5 x	0.46 x
EV / EBITDA	3.66 x	2.96 x	2.89 x	2.42 x	2.27 x	2.29 x	2.21 x	2.14 x
EV / FCF	-4.45 x	-6.09 x	-4.86 x	5.46 x	1.88 x	3.5 x	3.05 x	2.33 x
FCF Yield	-22.5%	-16.4%	-20.6%	18.3%	53.1%	28.6%	32.8%	42.9%
Price to Book	0.81 x	0.67 x	0.59 x	0.51 x	0.49 x	0.49 x	0.45 x	0.41 x
Nbr of stocks (in thousands)	1,716,305	1,716,305	1,891,540	1,891,540	1,891,540	1,891,540	-	-
Reference price ²	5.273	4.873	4.587	4.186	4.081	4.239	4.239	4.239
Announcement Date	3/24/20	3/31/21	3/29/22	3/29/23	3/27/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	6,816	8,521	9,914	11,912	13,650	14,597	16,047	17,545
EBITDA ¹	2,473	2,830	2,998	3,271	3,408	3,503	3,632	3,746
EBIT ¹	2,333	2,560	2,679	2,833	2,899	2,951	3,048	3,193
Operating Margin	34.23%	30.04%	27.02%	23.78%	21.24%	20.22%	18.99%	18.2%
Earnings before Tax (EBT) ¹	2,212	2,365	2,692	2,704	2,866	3,110	3,266	3,344
Net income ¹	1,489	1,648	1,835	1,890	2,021	2,139	2,306	2,380
Net margin	21.84%	19.33%	18.51%	15.87%	14.81%	14.65%	14.37%	13.57%
EPS ²	0.8700	0.9600	0.9100	0.9300	0.9900	1.062	1.159	1.200
Free Cash Flow ¹	-2,032	-1,373	-1,786	1,449	4,097	2,292	2,626	3,443
FCF margin	-29.82%	-16.11%	-18.01%	12.16%	30.02%	15.7%	16.37%	19.62%
FCF Conversion (EBITDA)	-	-	-	44.3%	120.24%	65.42%	72.32%	91.91%
FCF Conversion (Net income)	-	-	-	76.67%	202.74%	107.13%	113.92%	144.66%
Dividend per Share ²	0.2641	0.2613	0.2926	0.2982	0.3233	0.3367	0.3517	0.3750
Announcement Date	3/24/20	3/31/21	3/29/22	3/29/23	3/27/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt	34,076	-	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	13.78 x	-	-	-	-	-	-	-
Free Cash Flow ¹	-2,032	-1,373	-1,786	1,449	4,097	2,292	2,627	3,443
ROE (net income / shareholders' equity)	14.1%	14.8%	15.4%	14%	13.6%	12%	11.8%	11.4%
ROA (Net income/ Total Assets)	2.83%	2.93%	3.09%	2.84%	2.8%	2.85%	2.33%	2.59%
Assets ¹	52,555	56,280	59,393	66,550	72,176	75,050	98,954	91,892
Book Value Per Share ²	6.490	7.240	7.810	8.260	8.290	8.660	9.450	10.30
Cash Flow per Share	-1.060	-	-	-	-	-	-	-
Capex ¹	194	401	385	608	897	798	831	799
Capex / Sales	2.85%	4.7%	3.88%	5.1%	6.57%	5.47%	5.18%	4.55%
Announcement Date	3/24/20	3/31/21	3/29/22	3/29/23	3/27/24	-	-	-

¹CNY in Million²CNY

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.239 CNY

Average target price

6.488 CNY

Spread / Average Target

+53.05%

	1st Jan change	Capi.
GENERTEC UNIVERSAL MEDICAL GROUP COMPANY LIMITED	+1.78%	1.11B
FTAI AVIATION LTD.	+75.19%	8.22B
BOC AVIATION LIMITED	-3.10%	5.14B
GATX CORPORATION	+9.01%	4.67B
TOKYO CENTURY CORPORATION	-2.10%	4.59B
CHINA DEVELOPMENT BANK FINANCIAL LEASING CO., LTD.	+53.96%	3.46B
QNB FINANS FINANSAL KIRALAMA	+2.72%	3.34B
MIZUHO LEASING COMPANY, LIMITED	+13.12%	1.68B
CSSC (HONG KONG) SHIPPING COMPANY LIMITED	+8.78%	1.27B
GRENKE AG	-17.17%	1.04B